Action needed on breastfeeding data collection to gauge impact of medicines

A new systematic review from Swansea University in collaboration with ConcePTION, an Innovative Medicines Initiative (IMI), has called for action to monitor infants for any possible adverse drug reactions from exposure to medicines through breastmilk, even though problems may be rare; target additional support to breastfeeding patients whose medicines may affect breastfeeding; and provide long-term population-based data on any adverse events in infants exposed to medicines through breastmilk and any reduction in breastfeeding rates.